Wells Fargo’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-107,672
| Closed | -$7.3M | – | 7029 |
|
|
2019
Q3 | $7.3M | Sell |
107,672
-32,068
| -23% | -$2.2M | ﹤0.01% | 2200 |
|
|
2019
Q2 | $8.13M | Sell |
139,740
-6,009
| -4% | -$356K | ﹤0.01% | 2124 |
|
|
2019
Q1 | $10.2M | Sell |
145,749
-829
| -0.6% | -$61.5K | ﹤0.01% | 1928 |
|
|
2018
Q4 | $9.44M | Buy |
146,578
+89,254
| +156% | +$6.26M | ﹤0.01% | 1901 |
|
|
2018
Q3 | $4.03M | Buy |
57,324
+2,071
| +4% | +$121K | ﹤0.01% | 2825 |
|
|
2018
Q2 | $2.78M | Sell |
55,253
-2,704
| -5% | -$107K | ﹤0.01% | 3185 |
|
|
2018
Q1 | $1.81M | Sell |
57,957
-29,368
| -34% | -$974K | ﹤0.01% | 3457 |
|
|
2017
Q4 | $2.99M | Buy |
87,325
+18,441
| +27% | +$588K | ﹤0.01% | 3047 |
|
|
2017
Q3 | $2.21M | Buy |
68,884
+7,809
| +13% | +$246K | ﹤0.01% | 3227 |
|
|
2017
Q2 | $1.99M | Buy |
61,075
+9,391
| +18% | +$297K | ﹤0.01% | 3225 |
|
|
2017
Q1 | $1.63M | Sell |
51,684
-15,820
| -23% | -$468K | ﹤0.01% | 3364 |
|
|
2016
Q4 | $1.98M | Buy |
67,504
+7,116
| +12% | +$217K | ﹤0.01% | 3157 |
|
|
2016
Q3 | $1.75M | Sell |
60,388
-85
| -0.1% | -$2.37K | ﹤0.01% | 3078 |
|
|
2016
Q2 | $1.57M | Buy |
60,473
+1,062
| +2% | +$28.2K | ﹤0.01% | 3155 |
|
|
2016
Q1 | $1.47M | Buy |
59,411
+6,225
| +12% | +$171K | ﹤0.01% | 3140 |
|
|
2015
Q4 | $1.87M | Sell |
53,186
-3,722
| -7% | -$99.7K | ﹤0.01% | 3032 |
|
|
2015
Q3 | $1.2M | Buy |
56,908
+2,599
| +5% | +$67K | ﹤0.01% | 3372 |
|
|
2015
Q2 | $1.51M | Buy |
54,309
+7,372
| +16% | +$208K | ﹤0.01% | 3285 |
|
|
2015
Q1 | $1.43M | Sell |
46,937
-3,883
| -8% | -$123K | ﹤0.01% | 3274 |
|
|
2014
Q4 | $1.63M | Sell |
50,820
-655
| -1% | -$21.3K | ﹤0.01% | 3164 |
|
|
2014
Q3 | $1.46M | Buy |
51,475
+81
| +0.2% | +$2.26K | ﹤0.01% | 3209 |
|
|
2014
Q2 | $1.41M | Buy |
51,394
+9,530
| +23% | +$254K | ﹤0.01% | 3254 |
|
|
2014
Q1 | $1.1M | Sell |
41,864
-33,235
| -44% | -$954K | ﹤0.01% | 3426 |
|
|
2013
Q4 | $2.2M | Buy |
75,099
+2,320
| +3% | +$73.6K | ﹤0.01% | 2877 |
|
|
2013
Q3 | $2.23M | Buy |
72,779
+66,856
| +1,129% | +$2.24M | ﹤0.01% | 2817 |
|
|
2013
Q2 | $187K | Buy |
+5,923
| New | +$195K | ﹤0.01% | 4158 |
|
Wells Fargo's GHDX Position: Q4 2019 in Review
Wells Fargo sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 107,672 shares — an estimated $7.3M sold.
Wells Fargo first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $10.2M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Wells Fargo reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Wells Fargo sold 107,672 Genomic Health, Inc. shares in Q4 2019, an estimated $7.3M.
- Wells Fargo first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Wells Fargo's Genomic Health, Inc. position peaked at $10.2M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.